Pierre Desché - Concepedia

Author

Pierre Desché

Inserm ORCID

Also Known As

Desche, Pierre, P Desche, P Desché, P. DESCHE, P. Desche, P. Desché, Pierre Desche, Pierre Desché

Publications

582

Citations

H-Index

Concepts

All Affiliations

Inserm Servier (France)École Polytechnique Guerbet (France)Université Paris-Saclay

About

Pierre Desché is an author at Inserm specializing in medicine, cardiology, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	207
2	Pharmacology	3	3	100
3	Biochemistry	2	2	56
4	Cellular Physiology	2	2	56
5	Metabolism	1	1	20

Pierre Desché

Publications

378

Citations

H-Index

Page 1

	Year	Citations
Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study) Jing Hao, Philippe Bourrinet, Pierre Desché Investigative Radiology	2019	51
Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition Paul Mulder, L. Elfertak, Vincent Richard, American Journal of Physiology-Heart and Circulatory Physiology HypertensionHeart FailureAce InhibitionCardiovascular PharmacologyCardiovascular Function	1996	44
Adverse Reactions to Gadoterate Meglumine É. de Kerviler, Kenneth R. Maravilla, Jean-François Meder, Investigative Radiology	2016	40
Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure Philippe Lechat, Simon P. Garnham, Pierre Desché, American Heart Journal Heart FailureCardiovascular DiseaseCardiovascular PharmacologyPharmacotherapyCardiac Care	1993	38
Comparison of the effects of intravenous almitrine and positive end-expiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome J. F. Prost, Pierre Desché, F. Jardin, European Respiratory Journal Acute Lung InjuryAsthmaHeart FailureRespiratory Distress Syndrome (Pulmonary Critical Care)Positive End-expiratory Pressure	1991	37
Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain. Yves Lecarpentier, Catherine Coirault, Guy Lerebours, American Journal of Respiratory and Critical Care Medicine Molecular PharmacologyCardiomyopathyCardiac MuscleBiochemistryMedicine	1997	36
The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. J. Sennesael, Atif Ali, P. Sweny, British Journal of Clinical Pharmacology	1992	29
Sarcoplasmic reticulum Ca2+ pumps in heart and diaphragm of cardiomyopathic hamster: effects of perindopril Marielle Anger, F. Lambert, D. S. Chemla, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleAce InhibitionHeart FailureCardiomyopathic HamsterSerca Mrna Isoforms	1995	20
Long-term acceptability of perindopril: European multicenter trial on 856 patients Jean-Paul Degaute, Marc Leeman, Pierre Desché The American Journal of Medicine Clinical TrialsLong-term AcceptabilityPharmacotherapyMedicinePharmacoepidemiology	1992	19
Intrinsic alterations of diaphragm muscle in experimental cardiomyopathy Yves Lecarpentier, N Péry, Catherine Coirault, American Heart Journal MechanobiologyCardiac MuscleCardiomyopathyPhysiologyDiaphragm Muscle	1993	18

Page 1